Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17991442rdf:typepubmed:Citationlld:pubmed
pubmed-article:17991442lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:17991442lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:17991442lifeskim:mentionsumls-concept:C0007428lld:lifeskim
pubmed-article:17991442lifeskim:mentionsumls-concept:C0010654lld:lifeskim
pubmed-article:17991442lifeskim:mentionsumls-concept:C1947901lld:lifeskim
pubmed-article:17991442lifeskim:mentionsumls-concept:C1269955lld:lifeskim
pubmed-article:17991442lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:17991442pubmed:issue2lld:pubmed
pubmed-article:17991442pubmed:dateCreated2008-2-4lld:pubmed
pubmed-article:17991442pubmed:abstractTextCysteine cathepsins have been known for a long time to play an important role in cancer progression and metastasis. Several studies have proposed the concept of anti-cathepsin therapy in cancer treatment. On the other hand, cysteine cathepsins have been recently found to play a role in tumour cell death through mediation of apoptosis. The purpose of this mini-review is therefore to provide an insight into the mechanisms by which cysteine cathepsins modulate apoptosis and/or participate in tumour invasion, and to evaluate the impact of these enzymes on both tumour progression and development of potential strategies for cancer treatment.lld:pubmed
pubmed-article:17991442pubmed:languageenglld:pubmed
pubmed-article:17991442pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17991442pubmed:citationSubsetIMlld:pubmed
pubmed-article:17991442pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17991442pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17991442pubmed:statusMEDLINElld:pubmed
pubmed-article:17991442pubmed:monthFeblld:pubmed
pubmed-article:17991442pubmed:issn0300-9084lld:pubmed
pubmed-article:17991442pubmed:authorpubmed-author:TurkBorisBlld:pubmed
pubmed-article:17991442pubmed:authorpubmed-author:VasiljevaOlga...lld:pubmed
pubmed-article:17991442pubmed:issnTypePrintlld:pubmed
pubmed-article:17991442pubmed:volume90lld:pubmed
pubmed-article:17991442pubmed:ownerNLMlld:pubmed
pubmed-article:17991442pubmed:authorsCompleteYlld:pubmed
pubmed-article:17991442pubmed:pagination380-6lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:meshHeadingpubmed-meshheading:17991442...lld:pubmed
pubmed-article:17991442pubmed:year2008lld:pubmed
pubmed-article:17991442pubmed:articleTitleDual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion.lld:pubmed
pubmed-article:17991442pubmed:affiliationDepartment of Biochemistry and Molecular and Structural Biology, J. Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. olga.vasiljeva@ijs.silld:pubmed
pubmed-article:17991442pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17991442pubmed:publicationTypeReviewlld:pubmed
pubmed-article:17991442pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17991442lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17991442lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17991442lld:pubmed